Sign in to search for past news!
Dec. 23, 2025, 12:53 p.m.
Ipsen outlays $1bn for China-based Simcere's preclinical ADC
Ipsen outlays $1bn for China-based Simcere's preclinical ADC

Ipsen has become the latest Western pharma company to venture to China in search of ADC assets.

Ipsen outlays $1bn for China-based Simcere's preclinical ADC

Ipsen has become the latest Western pharma company to venture to China in search of ADC assets.

Pharmaceutical Technology
Sign in to see related stories!